AVTE logo

Aerovate Therapeutics (AVTE)

Profile

Full Name

Aerovate Therapeutics, Inc.

Ticker Symbol

AVTE

Exchange

NASDAQ

Country

United States

IPO

June 30, 2021

Indexes

Not included

Employees

30

Key Details

Price

$2.75(+2.61%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.44(+14.98% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

Apr 25, 2025

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Jun 18, 24 Wells Fargo
Equal-Weight
Jun 18, 24 TD Cowen
Hold
Jun 18, 24 Guggenheim
Neutral
Jun 18, 24 Evercore ISI Group
In-Line
Jun 17, 24 Jefferies
Hold
Jun 17, 24 BTIG
Neutral
Jun 6, 24 Wedbush
Outperform
May 22, 24 Wedbush
Outperform
May 14, 24 Wedbush
Outperform
Apr 1, 24 Wells Fargo
Overweight

Institutional Ownership

  • What is the ticker symbol for Aerovate Therapeutics?
  • Does Aerovate Therapeutics pay dividends?
  • What sector is Aerovate Therapeutics in?
  • What industry is Aerovate Therapeutics in?
  • What country is Aerovate Therapeutics based in?
  • When did Aerovate Therapeutics go public?
  • Is Aerovate Therapeutics in the S&P 500?
  • Is Aerovate Therapeutics in the NASDAQ 100?
  • Is Aerovate Therapeutics in the Dow Jones?
  • When was Aerovate Therapeutics's last earnings report?
  • When does Aerovate Therapeutics report earnings?
  • Should I buy Aerovate Therapeutics stock now?

What is the ticker symbol for Aerovate Therapeutics?

The ticker symbol for Aerovate Therapeutics is NASDAQ:AVTE

Does Aerovate Therapeutics pay dividends?

No, Aerovate Therapeutics does not pay dividends

What sector is Aerovate Therapeutics in?

Aerovate Therapeutics is in the Healthcare sector

What industry is Aerovate Therapeutics in?

Aerovate Therapeutics is in the Biotechnology industry

What country is Aerovate Therapeutics based in?

Aerovate Therapeutics is headquartered in United States

When did Aerovate Therapeutics go public?

Aerovate Therapeutics's initial public offering (IPO) was on June 30, 2021

Is Aerovate Therapeutics in the S&P 500?

No, Aerovate Therapeutics is not included in the S&P 500 index

Is Aerovate Therapeutics in the NASDAQ 100?

No, Aerovate Therapeutics is not included in the NASDAQ 100 index

Is Aerovate Therapeutics in the Dow Jones?

No, Aerovate Therapeutics is not included in the Dow Jones index

When was Aerovate Therapeutics's last earnings report?

Aerovate Therapeutics's most recent earnings report was on Nov 12, 2024

When does Aerovate Therapeutics report earnings?

The next expected earnings date for Aerovate Therapeutics is May 13, 2025

Should I buy Aerovate Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page